[go: up one dir, main page]

AU3014601A - Use of an enzyme to improve the resorption of medicaments in the tissue - Google Patents

Use of an enzyme to improve the resorption of medicaments in the tissue

Info

Publication number
AU3014601A
AU3014601A AU30146/01A AU3014601A AU3014601A AU 3014601 A AU3014601 A AU 3014601A AU 30146/01 A AU30146/01 A AU 30146/01A AU 3014601 A AU3014601 A AU 3014601A AU 3014601 A AU3014601 A AU 3014601A
Authority
AU
Australia
Prior art keywords
resorption
medicaments
enzyme
tissue
improve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30146/01A
Inventor
Albert Hartl
Manfred Kietzmann
Peter-Jurgen Muller
Jorg-Hermann Ozegowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
id pharma GmbH
Original Assignee
id pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by id pharma GmbH filed Critical id pharma GmbH
Publication of AU3014601A publication Critical patent/AU3014601A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AU30146/01A 1999-12-22 2000-12-19 Use of an enzyme to improve the resorption of medicaments in the tissue Abandoned AU3014601A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19963538 1999-12-22
DE1999163538 DE19963538A1 (en) 1999-12-22 1999-12-22 Use of an enzyme to improve tissue absorption of drugs
PCT/EP2000/012970 WO2001045743A2 (en) 1999-12-22 2000-12-19 Use of an enzyme to improve the resorption of medicaments in the tissue

Publications (1)

Publication Number Publication Date
AU3014601A true AU3014601A (en) 2001-07-03

Family

ID=7934845

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30146/01A Abandoned AU3014601A (en) 1999-12-22 2000-12-19 Use of an enzyme to improve the resorption of medicaments in the tissue

Country Status (3)

Country Link
AU (1) AU3014601A (en)
DE (1) DE19963538A1 (en)
WO (1) WO2001045743A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10143606A1 (en) * 2001-09-06 2003-03-27 Knoell Hans Forschung Ev Conservation of animal or human tissue for transplantation, e.g. kidney, heart, pancreas or liver, involves extracorporeal treatment with solution containing microbial hyaluronate-lyase or enzymatically active fragment
DE10207634B4 (en) * 2002-02-22 2011-03-10 Rainer Burckart Water basin with an internal, motor-driven treadmill for an animal or a human
WO2009037566A2 (en) * 2007-06-19 2009-03-26 Uvarkina Tamara P Hyaluronidase and method of use thereof
DE102007031417A1 (en) 2007-07-04 2009-01-08 Friedrich-Schiller-Universität Jena Hyaluronate lyase with a histidine tag e.g. useful in pharmaceutical formulations and medical products

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3708575A (en) * 1970-05-13 1973-01-02 Biorex Laboratories Ltd Method for the treatment of atherosclerosis employing glucuronoglycos-aminoglycan-hyaluronate-lyase
CH628088A5 (en) * 1975-09-17 1982-02-15 Dresden Arzneimittel Process for obtaining streptococcal metabolic products
DE19743899A1 (en) * 1997-10-04 1999-04-08 Univ Schiller Jena Activation of microbial hyaluronidase
JP2002533417A (en) * 1998-12-23 2002-10-08 エスパルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング Hyaluronate lyase used to enhance penetration of topically applied drugs
CA2318356A1 (en) * 1998-12-23 2000-07-06 Norbert Presselt Pharmaceutical formulation containing a hyaluronic acid-splitting enzyme of microbial origin
US6689349B1 (en) * 1998-12-23 2004-02-10 Esparma Gmbh Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis

Also Published As

Publication number Publication date
WO2001045743A2 (en) 2001-06-28
WO2001045743A3 (en) 2002-03-14
DE19963538A1 (en) 2001-07-05

Similar Documents

Publication Publication Date Title
AU6712500A (en) Improvements in or relating to sterilising preparations
AU5526399A (en) Improvements in or relating to the treatment of lesions
AU6372900A (en) Linkage of agents to tissue
AU6364700A (en) Human synthetases
AU715620C (en) Therapeutic methods and uses
AU1164601A (en) Therapeutic use and formulation
AU8038998A (en) Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters
AU3388400A (en) Human glycosylation enzymes
AU2121200A (en) Improvements in or relating to sphygmomanometers and other devices
AU6949200A (en) Human hydrolytic enzymes
AU2292301A (en) Human kinases
AU3978700A (en) Medical use
AU3014601A (en) Use of an enzyme to improve the resorption of medicaments in the tissue
AU5134600A (en) Full-length molecules expressed in human tissues
AU2462499A (en) Treatments to improve yields in the wet milling of corn
AU3760900A (en) Treatment of menstrual function
AU2001281950A1 (en) Regulation of human thimet oligopeptidase-like enzyme
AU1041801A (en) Improvements in or relating to an infuser
AU1959200A (en) New utilization of alpha-hidroxy-propionic acid in medicine
AU3064800A (en) The therapeutic use of r-warfarin as anticoagulant
AU1043601A (en) Medical use
AU5472899A (en) Human angiopoietin-3
AU4456800A (en) Human hac3
AUPQ361399A0 (en) Improvements in or relating to bells
AU4116500A (en) The use of alpha lipoic acid in the antimetastatic treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase